Summary
This 8-K filing from Alnylam Pharmaceuticals, Inc. (ALNY) on March 17, 2011, announces a significant event: the filing of a civil complaint against the company by Tekmira Pharmaceuticals Corporation and Protiva Biotherapeutics, Inc. The lawsuit, filed in Massachusetts, alleges misappropriation of confidential information and trade secrets, along with claims of unfair and deceptive trade practices. The plaintiffs are seeking both injunctive relief and unspecified damages.
Key Highlights
- 1Alnylam Pharmaceuticals is facing a civil lawsuit filed by Tekmira Pharmaceuticals and Protiva Biotherapeutics.
- 2The lawsuit alleges misappropriation of confidential information and trade secrets.
- 3Additional claims include unfair and deceptive trade practices, unjust enrichment, unfair competition, and false advertising.
- 4Plaintiffs are seeking injunctive relief and unspecified monetary damages.
- 5Alnylam Pharmaceuticals firmly believes the complaint is without merit and intends to vigorously defend itself.
- 6The event date of the complaint filing was March 16, 2011.
Frequently Asked Questions
A civil complaint has been filed by Tekmira Pharmaceuticals Corporation and Protiva Biotherapeutics, Inc., alleging misappropriation of confidential information and trade secrets, unfair and deceptive trade practices, unjust enrichment, unfair competition, and false advertising by Alnylam Pharmaceuticals.
The plaintiffs are seeking both injunctive relief, which would prevent Alnylam from continuing certain actions, and unspecified monetary damages.
Alnylam Pharmaceuticals firmly believes that the complaint is without merit or foundation and has stated its intention to fully defend itself in this matter.
The civil complaint was filed in the Business Litigation Section of the Suffolk County Superior Court, in Boston, Massachusetts.